- Capital Cube•last month
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to CytoSorbents Corp.Here are 5 ETF’s with the largest exposure to CTSO-US. Comparing the performance and risk of CytoSorbents Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns […] (Read more...) The post ETF’s with exposure to CytoSorbents Corp. : June 20, 2016 appeared first on CapitalCube.
- Zacks Small Cap Research•2 months ago
By Brian Marckx, CFA NYSE:FMS NASDAQ:CTSO Fresenius Commences Commercialization . While delayed from initial expectations, the long-awaited announcement that Fresenius (NYSE:FMS) has started selling CytoSorb ...
|Bid||4.60 x 5800|
|Ask||4.68 x 100|
|52wk Range||3.11 - 8.10|
|Day's Range||4.59 - 4.80|
|Avg Vol (3m)||64,598|
As of 2:49 PM EDT. NasdaqCM Real Time Price. Market open.